Skip to content

Author

Matthew Reaney

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

PRO‑CTCAE in Oncology Drug Evaluation: Cross-Agency Review of Regulatory and Health Technology Assessment Decision-Making in the United States and Europe.

Harmonized, cross-agency guidance on PRO-CTCAE item selection, endpoint definition, analysis, and presentation may help support its consistent and meaningful use in future oncology submissions and regulatory and HTA decision-making.

E. Basch, Matthew Reaney, J. Roydhouse et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.